4 August 2026
Latham & Watkins Advises CordenPharma on Acquisition of AmbioPharm
Advising firms
Deal team
35 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Maximilian Platzer Lead | Latham & Watkins LLP | Partner | Not stated | Frankfurt |
| David Beller Lead | Latham & Watkins LLP | Partner | Not stated | New York |
| Leah Sauter Lead | Latham & Watkins LLP | Partner | Not stated | New York |
| Thomas Forschbach | Latham & Watkins LLP | Partner | Not stated | London |
| Stephen Shi | Latham & Watkins LLP | Partner | Not stated | Hong Kong |
| Jaschar Mirkhani | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Jakob Baldes | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Marc Klepner | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Miles Gilhuly | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Owen Brody | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Blanka Fehn | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Matthew Dewitz | Latham & Watkins LLP | Partner | tax | New York |
| Adam Kestenbaum | Latham & Watkins LLP | Partner | benefits | Washington, D.C. |
| Hayden Rutledge | Latham & Watkins LLP | Associate | benefits | Not stated |
| Harrison White | Latham & Watkins LLP | Partner | representation and warranties insurance | Los Angeles |
| Enrique Covarrubias | Latham & Watkins LLP | Associate | representation and warranties insurance | Not stated |
| Joshua Tinkelman | Latham & Watkins LLP | Partner | financing | New York |
| Hugh O'Sullivan | Latham & Watkins LLP | Partner | financing | London |
| Julia Stapelfeld | Latham & Watkins LLP | Counsel | financing | Not stated |
| Emma Lynam | Latham & Watkins LLP | Associate | financing | Not stated |
| Eveline Van Keymeulen | Latham & Watkins LLP | Partner | life sciences and regulatory | Paris |
| Jason Caron | Latham & Watkins LLP | Partner | life sciences and regulatory | Washington, D.C. |
| Ben Haas | Latham & Watkins LLP | Partner | life sciences and regulatory | Washington, D.C. |
| Betty Pang | Latham & Watkins LLP | Partner | life sciences and regulatory | Bay Area |
| Jeanne Fabre | Latham & Watkins LLP | Associate | life sciences and regulatory | Not stated |
| Evan Miller | Latham & Watkins LLP | Associate | life sciences and regulatory | Not stated |
| Joseph Bargnesi | Latham & Watkins LLP | Partner | anti-corruption and antibribery and sanctions | Washington, D.C. |
| Andrew Galdes | Latham & Watkins LLP | Partner | anti-corruption and antibribery and sanctions | Washington, D.C. |
| Joelle Hageboutros | Latham & Watkins LLP | Associate | anti-corruption and antibribery and sanctions | Not stated |
| Morgan Brubaker | Latham & Watkins LLP | Partner | intellectual property | Washington, D.C. |
| Kellye Quirk | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Robert Blamires | Latham & Watkins LLP | Partner | data privacy | Bay Area |
| Kathryn Parsons-Reponte | Latham & Watkins LLP | Associate | data privacy | San Diego |
| David Langer | Latham & Watkins LLP | Counsel | EHS | Not stated |
| Lisa Brabant | Latham & Watkins LLP | Counsel | real estate | Not stated |
32 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- CordenPharmaBuy-side
- Counterparties
- AmbioPharm (Sell-side)